Minerva Neurosciences names Anthony Aliquo chief accounting officer
The board's move on August 10, 2026 shifts principal accounting officer duties away from CFO Fred Ahlholm, who stays on as finance chief.
SEC filing
Latest
2 stories
Wednesday, August 12
Friday, August 7
Minerva reports Q2 2026 results, confirms C19 trial timeline for roluperidone
Minerva said its confirmatory Phase 3 trial of roluperidone remains on track, with Phase A topline data expected in the second half of 2027 and Phase B data in the second half of 2028.
SEC filing